Report Detail
Global (United States, European Union and China) Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Research Report 2019-2025
- RnM3650530 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chinese hamster ovary cell (CHO) hepatitis B vaccine is considered to be the safe and effective method to prevent the hepatitis B infection. The major factor that fuels the growth of the market are increase in prevalence of hepatitis B infection worldwide. For example, approximately 887,000 deaths due to hepatitis B infection were recorded in 2015 across the globe. However, inherent disadvantages of using recombinant Chinese hamster ovary cell (CHO) to design hepatitis B vaccines restrains the growth of the market. Conversely, increase in government focus to promote (CHO) hepatitis B vaccination for adults and extensive research carried out for the same are expected to offer lucrative opportunities for the market.
In 2019, the market size of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine.
This report studies the global market size of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Merck & Co., Inc.
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Market Segment by Product Type
Pediatric Hepatitis B (CHO) Vaccine
Adult Hepatitis B (CHO) Vaccine
Market Segment by Application
Hospitals
Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Pediatric Hepatitis B (CHO) Vaccine
- 1.3.3 Adult Hepatitis B (CHO) Vaccine
- 1.4 Market Segment by Application
- 1.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size
- 2.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue 2014-2025
- 2.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 2014-2025
- 2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Growth Rate by Regions
- 2.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers
- 3.1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
- 3.6 Key Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Pediatric Hepatitis B (CHO) Vaccine Sales and Revenue (2014-2019)
- 4.1.2 Adult Hepatitis B (CHO) Vaccine Sales and Revenue (2014-2019)
- 4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type
- 4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type
- 4.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application
6 United States
- 6.1 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Company
- 6.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Type
- 6.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Company
- 7.2 European Union Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Type
- 7.3 European Union Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Application
8 China
- 8.1 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Company
- 8.2 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Type
- 8.3 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Company
- 9.2 Rest of World Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Type
- 9.3 Rest of World Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Application
- 9.4 Rest of World Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Countries
- 9.4.2 Rest of World Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Merck & Co., Inc.
- 10.1.1 Merck & Co., Inc. Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
- 10.1.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
- 10.1.5 Merck & Co., Inc. Recent Development
- 10.2 GlaxoSmithKline Plc
- 10.2.1 GlaxoSmithKline Plc Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
- 10.2.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
- 10.2.5 GlaxoSmithKline Plc Recent Development
- 10.3 Pfizer Inc.
- 10.3.1 Pfizer Inc. Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
- 10.3.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
- 10.3.5 Pfizer Inc. Recent Development
- 10.4 Sanofi Pasteur
- 10.4.1 Sanofi Pasteur Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
- 10.4.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
- 10.4.5 Sanofi Pasteur Recent Development
- 10.5 CSL Limited
- 10.5.1 CSL Limited Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
- 10.5.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
- 10.5.5 CSL Limited Recent Development
- 10.6 Emergent Biosolutions
- 10.6.1 Emergent Biosolutions Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
- 10.6.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
- 10.6.5 Emergent Biosolutions Recent Development
- 10.7 Serum Institute of India
- 10.7.1 Serum Institute of India Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
- 10.7.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
- 10.7.5 Serum Institute of India Recent Development
- 10.8 Johnson & Johnson
- 10.8.1 Johnson & Johnson Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
- 10.8.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
- 10.8.5 Johnson & Johnson Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels
- 11.2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
- 11.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers
12 Market Forecast
- 12.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Type
- 12.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Application
- 12.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecast by Regions
- 12.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine. Industry analysis & Market Report on Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is a syndicated market report, published as Global (United States, European Union and China) Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
